MacroGenics, Inc. (MGNX)
3.52
+0.11
(+3.23%)
USD |
NASDAQ |
Apr 17, 12:34
MacroGenics Cash from Investing (Quarterly) : -65.99M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -693.00M |
| Amicus Therapeutics, Inc. | -6.494M |
| Merck & Co., Inc. | -11.20B |
| Pfizer Inc. | -6.146B |
| Xencor, Inc. | 72.90M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 43.02M |
| Cash from Financing (Quarterly) | 0.057M |
| Free Cash Flow | -82.95M |
| Free Cash Flow Per Share (Quarterly) | 0.6756 |
| Free Cash Flow to Equity (Quarterly) | 43.28M |
| Free Cash Flow to Firm (Quarterly) | 46.83M |
| Free Cash Flow Yield | -37.30% |